PCSC

Perceptive Capital Solutions Corp Class A Ordinary Shares
NASDAQFINANCIAL SERVICESSHELL COMPANIES

Key Statistics

Market Cap
$118.61M
P/E Ratio
575.00
EPS
$0.02
Beta
0.36
52W High
$14.47
52W Low
$10.54
50-Day MA
$11.16
200-Day MA
$11.65
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Perceptive Capital Solutions Corp Class A Ordinary Shares

Perceptive Capital Solutions Corp (PCSC) is an innovative investment management firm focused on identifying and capitalizing on high-growth opportunities across diverse sectors. Utilizing advanced analytics and in-depth market insights, PCSC strategically develops tailored investment strategies designed to optimize portfolio performance in ever-evolving market conditions. Committed to maximizing shareholder value, the firm has established itself as a trusted partner for institutional investors by adeptly navigating market complexities and leveraging emerging trends to deliver superior returns.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA
Operating Margin0.00%
Return on Equity0.00%
Return on Assets-2.04%
Revenue/Share (TTM)$0.00
Book Value$-0.51
Price-to-Book1.30
Price-to-Sales (TTM)
EV/Revenue-
EV/EBITDA
Quarterly Earnings Growth (YoY)-85.30%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$8.16M
Float$2.85M
% Insiders3.51%
% Institutions131.34%

Historical Volatility

HV 10-Day
33.67%
HV 20-Day
25.51%
HV 30-Day
21.32%
HV 60-Day
16.86%
HV Rank
66.3%

Volatility is currently expanding

Latest News

Perceptive Capital Solutions Corp Announces Change of Date of Extraordinary General Meeting of Shareholders

– Extraordinary General Meeting of Perceptive Shareholders Postponed to July 15, 2026 NEW YORK, July 9, 2026 /PRNewswire/ -- Perceptive Capital Solutions Corp ("PCSC") (Nasdaq: PCSC), a special purpose acquisition company ("SPAC") sponsored by an affiliate of Perceptive Advisors, announced today that the extraordinary general meeting of shareholders of PCSC (the "Extraordinary General Meeting"), originally scheduled for July 9, 2026 at 10:00 a.m. Eastern Time, to approve proposals related to the proposed business combination (the "Business Combination") between PCSC and Freenome Holdings, Inc. ("Freenome"), an early cancer detection company developing blood-based screening tests has been postponed to July 15, 2026 at 10:00 a.m.

PRNewsWire7/9/2026Neutral

More FINANCIAL SERVICES Stocks

Data last updated: 7/9/2026